MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-UP-15-0005230
Earl Pharmaceuticals Private Limited
Earl Pharmaceuticals Private Limited - trading in Bareilly, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹39.67 Lakh
▲ 32% YoY
Net profit · FY 2025
₹41,427
Net margin 1%
EBITDA · FY 2025
₹55,983
EBITDA margin 1.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Open charges
₹15 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Earl Pharmaceuticals Private Limited
Data last updated:
Earl Pharmaceuticals Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 01 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24299UP2016PTC085305. Its GSTIN is 09AAECE4101B1ZC (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It was formerly known as Sunup Pharmaceuticals Private Limited and Aurora Pharmaceuticals Private Limited. It is led by directors Bhawana Srivastava and Sandeep Kumar Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 91 Officers Enclave Karam Chari Nagar, Bareilly, Uttar Pradesh, India – 243001.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.67 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹41,427 (net margin 1%) and EBITDA of ₹55,983 (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years.
As per MCA filings, the company has open charges of ₹15 Lakh on record.
Earl Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-15-0005230). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Earl Pharmaceuticals Private Limited
CIN U24299UP2016PTC085305
Registration Number 085305
Incorporation Date 01 August 2016
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-15-0005230
Name History of Earl Pharmaceuticals Private Limited
Earl Pharmaceuticals has undergone 3 name changes throughout its history. The company was previously known as Sunup Pharmaceuticals Private Limited, Aurora Pharmaceuticals Private Limited, and Benison Pharmaceuticals Private Limited. The current legal name is Earl Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Earl Pharmaceuticals Private Limited | Current |
| Sunup Pharmaceuticals Private Limited | Previous |
| Aurora Pharmaceuticals Private Limited | Previous |
| Benison Pharmaceuticals Private Limited | Previous |
Recognitions & Rankings of Earl Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address91 Officers Enclave Karam Chari Nagar, Bareilly, Uttar Pradesh, India – 243001
- IndustryTrading, Other Wholesale, Wholesale
Comprehensive company report
Earl Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Earl Pharmaceuticals Private Limited
The main business activity of Earl Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Earl Pharmaceuticals Private Limited FY 2025 filings available
Earl Pharmaceuticals Private Limited reported revenue of ₹39.67 Lakh (up 32% YoY) for FY 2025.
Revenue · FY 2025
₹39.67 Lakh ▲ 32%
Net profit · FY 2025
₹41,427 margin 1%
EBITDA · FY 2025
₹55,983 margin 1.4%
Compounded Annual Growth Rate (CAGR) of Earl Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 34%
EBITDA CAGR growth
1 year
▲ 49%
3 years · compounded
▲ 20%
5 years · compounded
▲ 36%
Revenue has grown at a compounded annual rate (CAGR) of 34% over three years, including 32% growth in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Earl Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹55,983 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹41,427 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Earl Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Earl Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Earl Pharmaceuticals Private Limited
Earl Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhawana Srivastava | Director | 20 Feb 2024 | 2 Years 8 Months | Current |
| Sandeep Kumar Srivastava | Director | 12 Aug 2022 | 4 Years 2 Months | Current |
Peer Comparison of Earl Pharmaceuticals Private Limited
Earl Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Welltass Pharmaceuticals Private Limited | ₹39.92 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Greater Noida, Uttar Pradesh, India |
| Axonwave Pharmaceuticals Private Limited | ₹39.76 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | Uttamnagar, Delhi, India |
| Coris Chemicals and Pharmaceuticals Private Limited | ₹39.7 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Surat, Gujarat, India |
| Nihit Pharmaceuticals Private Limited | ₹39.68 Lakh (FY 2021) | •••• | •••• | 560.0% | •••• | Pune, Maharashtra, India |
| Delmax Pharmaceuticals Private Limited | ₹39.68 Lakh (FY 2024) | •••• | •••• | -5.0% | •••• | Aurangabad, Maharashtra, India |
| Earl Pharmaceuticals Private Limited this company | ₹39.67 Lakh (FY 2025) | •••• | •••• | 32.0% | •••• | Bareilly, Uttar Pradesh, India |
| Pharmella Pharmaceuticals Private Limited | ₹39.64 Lakh (FY 2025) | •••• | •••• | 13.0% | •••• | Eluru, Andhra Pradesh, India |
| Admiris Pharmaceuticals Private Limited | ₹39.6 Lakh (FY 2025) | •••• | •••• | 80.0% | •••• | Dhubri, Assam, India |
| Bhashaja Pharmaceuticals Private Limited | ₹39.57 Lakh (FY 2024) | •••• | •••• | 0.0% | •••• | Kolkata, West Bengal, India |
| Asap Pharmaceuticals Private Limited | ₹39.48 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Patna, Bihar, India |
| Jainson Pharmaceuticals Private Limited | ₹39.48 Lakh (FY 2025) | •••• | •••• | 69.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Earl Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Earl Pharmaceuticals Private Limited
Earl Pharmaceuticals Private Limited is audited by RAJAN SHUKLA & CO. for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAJAN SHUKLA & CO. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Earl Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Earl Pharmaceuticals Private Limited
Open charges
₹15 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2023 | State Bank of India | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Earl Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Earl Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Earl Pharmaceuticals Private Limited
Earl Pharmaceuticals Private Limited has 6 board changes on record since 2016: 4 appointments and 2 cessations. The latest: Ayushi Srivastava ceased to be Director on 20 Feb 2024.
AGM
Earl Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Earl Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Ceased
Ayushi Srivastava ceased to be Director.
Appointed
Bhawana Srivastava was appointed as Director.
Charges
A charge with State Bank Of India amounted to Rs. 15.00 Lakh with Charge ID 100685362 was registered on 27 Feb 2023.
Appointed
Sandeep Kumar Srivastava was appointed as Director.
Ceased
Anjuli Srivastava ceased to be Director.
Appointed
Ayushi Srivastava was appointed as Director.
Appointed
Anjuli Srivastava was appointed as Director.
Incorporation
01 Aug 2016
Earl Pharmaceuticals Private Limited was registered on 01 Aug 2016 with Roc Kanpur & aged 10 years 2 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Earl Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Earl Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Earl Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Earl Pharmaceuticals Private Limited
Earl Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECE4101B1ZC | Uttar Pradesh | Active | 16 Mar 2021 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Earl Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Earl Pharmaceuticals Private Limited
Earl Pharmaceuticals is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 01 August 2016 (10+ years old) and is registered under CIN U24299UP2016PTC085305.
Earl Pharmaceuticals reported revenue of ₹39.67 Lakh for FY 2025 (up 32% YoY).
Earl Pharmaceuticals has 2 current directors:
- Bhawana Srivastava - Director
- Sandeep Kumar Srivastava - Director
Earl Pharmaceuticals reported a net profit of ₹41,427 (net margin 1%) and EBITDA of ₹55,983 (EBITDA margin 1.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Earl Pharmaceuticals is 34% over three years. In the latest year (FY 2025) revenue rose 32%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Earl Pharmaceuticals is 09AAECE4101B1ZC, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Earl Pharmaceuticals is U24299UP2016PTC085305. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Earl Pharmaceuticals was incorporated on 01 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Earl Pharmaceuticals by revenue are Welltass Pharmaceuticals Private Limited, Axonwave Pharmaceuticals Private Limited, Coris Chemicals and Pharmaceuticals Private Limited, Nihit Pharmaceuticals Private Limited, Delmax Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Ayushi Srivastava ceased to be Director on 20 Feb 2024. Bhawana Srivastava was appointed as Director on 20 Feb 2024. Sandeep Kumar Srivastava was appointed as Director on 12 Aug 2022. Earl Pharmaceuticals has 6 board changes on record in total.
Yes, Earl Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-15-0005230).